Skip to content
Screener

Inspire Medical Systems INSP Q1 2026 earnings

Reported May 4, 2026 · After market close

Revenue$204.6MBeat by $4.5M
EPS$0.10Beat by $0.38
Revenue estimate$200.0M
EPS estimate-$0.28

Next report

Nov 2, 2026 (in a month)
Revenue estimate$204.2M
EPS estimate$0.11

Financials

Q1 2026

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.49B-68.7%
Enterprise value$1.42B-70.0%
P/E11.3×-59.9×
P/S1.6×-4.0×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0×0.0×
Current ratio6.3×-2.7×

Segments

By segment

See full
Operating Segment$204.6M+1.6%

FAQ

When did Inspire Medical Systems report Q1 2026 earnings?
Inspire Medical Systems (INSP) reported Q1 2026 earnings on May 4, 2026 after market close.
What were Inspire Medical Systems's Q1 2026 revenue and EPS?
Inspire Medical Systems reported revenue of $204.6M and eps of $0.10 for Q1 2026.
Did Inspire Medical Systems beat estimates in Q1 2026?
Revenue beat the consensus estimate of $200.0M by $4.5M. EPS beat the consensus estimate of $-0.28 by $0.38.
How did Inspire Medical Systems's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.6% from $201.3M a year earlier and eps grew 0.0% from $0.10.
Where can I find Inspire Medical Systems's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001609550-26-000021) and the 10-Q periodic report (0001609550-26-000023) directly on SEC EDGAR. The filing index links above go to sec.gov.